AnalystsKeith TapperKeith Tapper's Stock Forecasts
AnalystsKeith Tapper
Sectors:
Industries:
Analyst Ranking
Top 43%
#2215 out of 5177 analysts
Average Return
+11.64%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Keith Tapper's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neurogene IncNGNE | +61.16% | $10.89 | $17.55 | 2025-04-13 - 2026-01-16 | Buy |
Neurogene IncNGNE | +36.92% | $15.33 | $20.99 | 2024-11-19 - 2025-11-19 | Buy |
Acadia Pharmaceuticals IncACAD | +35.68% | $16.37 | $22.21 | 2024-06-26 - 2025-06-26 | Buy |
Taysha Gene Therapies IncTSHA | +11.32% | $2.17 | $2.41 | 2024-06-26 - 2025-06-26 | Buy |
Keith Tapper Analyst Color
Get additional color on Keith Tapper's coverage of popular stocks
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.